Cargando…

Efficient development and usability testing of decision support interventions for older women with breast cancer

BACKGROUND: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 years. However, there are currently no decision support interventions (DESIs) for older women who have a choice between primary endocrine therapy and surgery followed by adjuvant endocrine therapy (su...

Descripción completa

Detalles Bibliográficos
Autores principales: Lifford, Kate J, Edwards, Adrian, Burton, Maria, Harder, Helena, Armitage, Fiona, Morgan, Jenna L, Caldon, Lisa, Balachandran, Kirsty, Ring, Alistair, Collins, Karen, Reed, Malcolm, Wyld, Lynda, Brain, Kate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338238/
https://www.ncbi.nlm.nih.gov/pubmed/30679905
http://dx.doi.org/10.2147/PPA.S178347
_version_ 1783388425706012672
author Lifford, Kate J
Edwards, Adrian
Burton, Maria
Harder, Helena
Armitage, Fiona
Morgan, Jenna L
Caldon, Lisa
Balachandran, Kirsty
Ring, Alistair
Collins, Karen
Reed, Malcolm
Wyld, Lynda
Brain, Kate
author_facet Lifford, Kate J
Edwards, Adrian
Burton, Maria
Harder, Helena
Armitage, Fiona
Morgan, Jenna L
Caldon, Lisa
Balachandran, Kirsty
Ring, Alistair
Collins, Karen
Reed, Malcolm
Wyld, Lynda
Brain, Kate
author_sort Lifford, Kate J
collection PubMed
description BACKGROUND: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 years. However, there are currently no decision support interventions (DESIs) for older women who have a choice between primary endocrine therapy and surgery followed by adjuvant endocrine therapy (surgery+endocrine therapy), or who can choose whether or not to have chemotherapy following surgery. There is also little evidence-based guidance specifically on the management of these older patients. A large UK cohort study is currently underway to address this lack of evidence and to develop two DESIs to facilitate shared decision-making with older women about breast cancer treatments. Here, we present the development and initial testing of these two DESIs. METHODS: An initial prototype DESI was developed for the choice of primary endocrine therapy or surgery+endocrine therapy. Semi-structured interviews with healthy volunteers and patients explored DESI acceptability, usability, and utility. A framework approach was used for analysis. A second DESI for the choice of having chemotherapy or not was subsequently developed based on more focused development and testing. RESULTS: Participants (n=22, aged 75–94 years, 64% healthy volunteers, 36% patients) found the primary endocrine therapy /surgery+endocrine therapy DESI acceptable, and contributed to improved wording and illustrations to address misunderstandings. The chemotherapy DESI (tested with 14 participants, aged 70–87 years, 57% healthy volunteers, 43% patients) was mostly understandable, however, suggestions for rewording sections were made. Most participants considered the DESIs helpful, but highlighted the importance of complementary discussions with clinicians. CONCLUSION: It was possible to use a template DESI to efficiently create a second prototype for a different treatment option (chemotherapy). Both DESIs were acceptable and considered helpful to support/augment consultations. Development of acceptable additional DESIs for similar target populations using simplified methods may be an efficient way to develop future DESIs. Further research is needed to test the effectiveness of the DESIs.
format Online
Article
Text
id pubmed-6338238
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63382382019-01-24 Efficient development and usability testing of decision support interventions for older women with breast cancer Lifford, Kate J Edwards, Adrian Burton, Maria Harder, Helena Armitage, Fiona Morgan, Jenna L Caldon, Lisa Balachandran, Kirsty Ring, Alistair Collins, Karen Reed, Malcolm Wyld, Lynda Brain, Kate Patient Prefer Adherence Original Research BACKGROUND: Around one-third of breast cancers diagnosed every year in the UK are in women aged ≥70 years. However, there are currently no decision support interventions (DESIs) for older women who have a choice between primary endocrine therapy and surgery followed by adjuvant endocrine therapy (surgery+endocrine therapy), or who can choose whether or not to have chemotherapy following surgery. There is also little evidence-based guidance specifically on the management of these older patients. A large UK cohort study is currently underway to address this lack of evidence and to develop two DESIs to facilitate shared decision-making with older women about breast cancer treatments. Here, we present the development and initial testing of these two DESIs. METHODS: An initial prototype DESI was developed for the choice of primary endocrine therapy or surgery+endocrine therapy. Semi-structured interviews with healthy volunteers and patients explored DESI acceptability, usability, and utility. A framework approach was used for analysis. A second DESI for the choice of having chemotherapy or not was subsequently developed based on more focused development and testing. RESULTS: Participants (n=22, aged 75–94 years, 64% healthy volunteers, 36% patients) found the primary endocrine therapy /surgery+endocrine therapy DESI acceptable, and contributed to improved wording and illustrations to address misunderstandings. The chemotherapy DESI (tested with 14 participants, aged 70–87 years, 57% healthy volunteers, 43% patients) was mostly understandable, however, suggestions for rewording sections were made. Most participants considered the DESIs helpful, but highlighted the importance of complementary discussions with clinicians. CONCLUSION: It was possible to use a template DESI to efficiently create a second prototype for a different treatment option (chemotherapy). Both DESIs were acceptable and considered helpful to support/augment consultations. Development of acceptable additional DESIs for similar target populations using simplified methods may be an efficient way to develop future DESIs. Further research is needed to test the effectiveness of the DESIs. Dove Medical Press 2019-01-14 /pmc/articles/PMC6338238/ /pubmed/30679905 http://dx.doi.org/10.2147/PPA.S178347 Text en © 2019 Lifford et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Lifford, Kate J
Edwards, Adrian
Burton, Maria
Harder, Helena
Armitage, Fiona
Morgan, Jenna L
Caldon, Lisa
Balachandran, Kirsty
Ring, Alistair
Collins, Karen
Reed, Malcolm
Wyld, Lynda
Brain, Kate
Efficient development and usability testing of decision support interventions for older women with breast cancer
title Efficient development and usability testing of decision support interventions for older women with breast cancer
title_full Efficient development and usability testing of decision support interventions for older women with breast cancer
title_fullStr Efficient development and usability testing of decision support interventions for older women with breast cancer
title_full_unstemmed Efficient development and usability testing of decision support interventions for older women with breast cancer
title_short Efficient development and usability testing of decision support interventions for older women with breast cancer
title_sort efficient development and usability testing of decision support interventions for older women with breast cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338238/
https://www.ncbi.nlm.nih.gov/pubmed/30679905
http://dx.doi.org/10.2147/PPA.S178347
work_keys_str_mv AT liffordkatej efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT edwardsadrian efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT burtonmaria efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT harderhelena efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT armitagefiona efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT morganjennal efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT caldonlisa efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT balachandrankirsty efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT ringalistair efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT collinskaren efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT reedmalcolm efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT wyldlynda efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer
AT brainkate efficientdevelopmentandusabilitytestingofdecisionsupportinterventionsforolderwomenwithbreastcancer